Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Crawford Nomination Suggests Stability For Supplements, OTC Regulation

This article was originally published in The Tan Sheet

Executive Summary

Confirmation of Lester Crawford as permanent FDA commissioner would provide the consumer health industries with a known variable for at least the next four years

You may also be interested in...



Crawford Must Answer “Tough Questions” During Confirmation – Grassley

Sen. Charles Grassley (R-Iowa) is noncommittal on the nomination of FDA Acting Commissioner Lester Crawford to fill the post on a permanent basis

Crawford Must Answer “Tough Questions” During Confirmation – Grassley

Sen. Charles Grassley (R-Iowa) is noncommittal on the nomination of FDA Acting Commissioner Lester Crawford to fill the post on a permanent basis

Crawford Must Answer “Tough Questions” During Confirmation – Grassley

Sen. Charles Grassley (R-Iowa) is noncommittal on the nomination of FDA Acting Commissioner Lester Crawford to fill the post on a permanent basis

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097868

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel